Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
13009 | 803 | 41.7 | 94% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1396 | 7607 | GENET CELL BIOL SECTCHUO KU//WNT//GENET CELL BIOL SECT |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DKK 3 | Author keyword | 44 | 88% | 3% | 21 |
2 | REIC | Author keyword | 33 | 100% | 2% | 13 |
3 | REIC DKK 3 | Author keyword | 26 | 100% | 1% | 11 |
4 | SECRETED FRIZZLED RELATED PROTEIN 5 | Author keyword | 26 | 100% | 1% | 11 |
5 | DICKKOPF 3 | Author keyword | 26 | 80% | 2% | 16 |
6 | DKK3 | Author keyword | 25 | 77% | 2% | 17 |
7 | SFRP | Author keyword | 17 | 41% | 4% | 32 |
8 | INNOVAT OKAYAMA NANOBIOTARGETED THER Y | Address | 17 | 72% | 2% | 13 |
9 | SFRP1 | Author keyword | 16 | 39% | 4% | 32 |
10 | WNT ANTAGONIST | Author keyword | 13 | 69% | 1% | 11 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DKK 3 | 44 | 88% | 3% | 21 | Search DKK+3 | Search DKK+3 |
2 | REIC | 33 | 100% | 2% | 13 | Search REIC | Search REIC |
3 | REIC DKK 3 | 26 | 100% | 1% | 11 | Search REIC+DKK+3 | Search REIC+DKK+3 |
4 | SECRETED FRIZZLED RELATED PROTEIN 5 | 26 | 100% | 1% | 11 | Search SECRETED+FRIZZLED+RELATED+PROTEIN+5 | Search SECRETED+FRIZZLED+RELATED+PROTEIN+5 |
5 | DICKKOPF 3 | 26 | 80% | 2% | 16 | Search DICKKOPF+3 | Search DICKKOPF+3 |
6 | DKK3 | 25 | 77% | 2% | 17 | Search DKK3 | Search DKK3 |
7 | SFRP | 17 | 41% | 4% | 32 | Search SFRP | Search SFRP |
8 | SFRP1 | 16 | 39% | 4% | 32 | Search SFRP1 | Search SFRP1 |
9 | WNT ANTAGONIST | 13 | 69% | 1% | 11 | Search WNT+ANTAGONIST | Search WNT+ANTAGONIST |
10 | WIF 1 | 12 | 59% | 2% | 13 | Search WIF+1 | Search WIF+1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | REIC DKK 3 | 61 | 86% | 4% | 31 |
2 | WNT ANTAGONIST SFRP1 | 47 | 86% | 3% | 24 |
3 | ANTAGONIST FAMILY GENES | 29 | 88% | 2% | 14 |
4 | DICKKOPF 3 | 27 | 92% | 1% | 11 |
5 | SFRP GENES | 17 | 55% | 3% | 21 |
6 | WNT ANTAGONIST | 16 | 52% | 3% | 22 |
7 | BETA CATENIN TCF | 15 | 49% | 3% | 23 |
8 | FRZB 1 | 15 | 82% | 1% | 9 |
9 | DKK1 | 13 | 34% | 4% | 30 |
10 | FRIZZLED RELATED PROTEINS | 12 | 37% | 3% | 27 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease | 2008 | 223 | 114 | 47% |
Targeting the Wnt pathway in cancer: The emerging role of Dickkopf-3 | 2012 | 36 | 113 | 69% |
Secreted frizzled related proteins: Implications in cancers | 2014 | 8 | 188 | 39% |
Function and biological roles of the Dickkopf family of Wnt modulators | 2006 | 366 | 121 | 32% |
Dickkopf1: A tumor suppressor or metastasis promoter? | 2012 | 22 | 77 | 48% |
Cellcell interaction in the heart via Wnt/-catenin pathway after cardiac injury | 2014 | 4 | 61 | 41% |
Epigenetic disruption of the WNT/beta-catenin signaling pathway in human cancers | 2009 | 72 | 81 | 32% |
The Advantages and Disadvantages of Sfrp1 and Sfrp2 Expression in Pathological Events | 2010 | 20 | 86 | 57% |
WNT Signaling in Adult Cardiac Hypertrophy and Remodeling Lessons Learned From Cardiac Development | 2010 | 46 | 62 | 32% |
Secreted Frizzled-related proteins: searching for relationships and patterns | 2002 | 244 | 73 | 48% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INNOVAT OKAYAMA NANOBIOTARGETED THER Y | 17 | 72% | 1.6% | 13 |
2 | CANC STEM CELLS CARDIOVASC REGENERAT | 6 | 80% | 0.5% | 4 |
3 | WHO ABORATING CANC | 2 | 50% | 0.4% | 3 |
4 | TRANSGENE TECHNOL | 2 | 43% | 0.4% | 3 |
5 | PIONEER VALLEY LIFE SCI | 2 | 19% | 0.9% | 7 |
6 | INNOVAT OKAYAMA NANOBIOTARGETED THER Y ICONT | 1 | 100% | 0.2% | 2 |
7 | KMT | 1 | 15% | 0.9% | 7 |
8 | NEUROBIOL DESARROLLO | 1 | 17% | 0.6% | 5 |
9 | NEUROBIOL MOL CELULAR DESARROLLO | 1 | 21% | 0.4% | 3 |
10 | CAN SCI SING ORE | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000248914 | BETA CATENIN//AXIN//WNT |
2 | 0.0000197917 | SCLEROSTIN//SOST//LRP5 |
3 | 0.0000191204 | ROR2//ROBINOW SYNDROME//WNT5A |
4 | 0.0000137425 | GENET CELL BIOL SECTCHUO KU//GENET CELL BIOL SECT//INTEGROME NETWORK |
5 | 0.0000119499 | MOUSE HEPATOCARCINOGENESIS//METABOLIC ZONATION//EXPT PATHOL EP |
6 | 0.0000071790 | NORRIE DISEASE//FAMILIAL EXUDATIVE VITREORETINOPATHY//FRIZZLED 4 |
7 | 0.0000071461 | MIR 1260B//NOUVEL HOP ESTAING//DIETARY COMPOUNDS |
8 | 0.0000062191 | PLANAR CELL POLARITY//VANGL2//CONVERGENT EXTENSION |
9 | 0.0000052155 | ZNF703//C8ORF4//8P12 |
10 | 0.0000051343 | CHFR//EPIGENETCANC//P41 ARC |